1
Hagendijk, Marije E, van der Schans, Simon, Boersma, Cornelis, Postma, Maarten J, van der Pol, Simon
Veröffentlicht in: Hagendijk , M E , van der Schans , S , Boersma , C , Postma , M J & van der Pol , S 2021 , ' Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands ' , European Journal of Health Economics , vol. 22 , no. 6 , pp. 991-999 . https://doi.org/10.1007/s10198-021-01303-2;
2021
Veröffentlicht in: Hagendijk , M E , van der Schans , S , Boersma , C , Postma , M J & van der Pol , S 2021 , ' Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands ' , European Journal of Health Economics , vol. 22 , no. 6 , pp. 991-999 . https://doi.org/10.1007/s10198-021-01303-2;
2021